Lilly Acquiring Kelonia In Largest Funded Biotech Startup Purchase In Years

This acquisition highlights the immense value and potential of AI-driven drug discovery and development, particularly in complex fields like gene therapy. Large pharmaceutical companies are increasingly recognizing the need to integrate cutting-edge AI capabilities to accelerate innovation and secure future growth.